Do analysts rate APYX or QTI?

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 51.16%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Apyx Medical is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation & earnings, APYX or QTI?

Apyx Medical has higher revenue and earnings than QT Imaging. Apyx Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 3.41 -$11.21M -$0.22 N/A QT Imaging $22.66M 2.15 -$21.08M -$1.24 N/A

Is APYX or QTI more profitable?

Apyx Medical has a net margin of -16.40% compared to QT Imaging's net margin of -58.93%. Apyx Medical's return on equity of -88.47% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -16.40% -88.47% -14.94% QT Imaging -58.93% -4,220.38% -51.77%

Does the media refer more to APYX or QTI?

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. QT Imaging's average media sentiment score of 1.34 beat Apyx Medical's score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral QT Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate QTI or HYPR?

Hyperfine has a consensus price target of $1.78, suggesting a potential upside of 37.18%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts plainly believe Hyperfine is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Hyperfine 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has stronger valuation and earnings, QTI or HYPR?

QT Imaging has higher revenue and earnings than Hyperfine. QT Imaging is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QT Imaging $22.66M 2.15 -$21.08M -$1.24 N/A Hyperfine $11.40M 11.32 -$35.57M -$0.41 N/A

Is QTI or HYPR more profitable?

QT Imaging has a net margin of -58.93% compared to Hyperfine's net margin of -226.88%. Hyperfine's return on equity of -98.83% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -58.93% -4,220.38% -51.77% Hyperfine -226.88% -98.83% -67.09%

Does the media prefer QTI or HYPR?

In the previous week, Hyperfine had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Hyperfine and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.34 beat Hyperfine's score of 0.00 indicating that QT Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QT Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hyperfine 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend QTI or STEX?

Biosig Technologies has a consensus price target of $8.00, suggesting a potential upside of 724.15%. Given Biosig Technologies' higher possible upside, analysts clearly believe Biosig Technologies is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Biosig Technologies 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer QTI or STEX?

In the previous week, Biosig Technologies had 1 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Biosig Technologies and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.34 beat Biosig Technologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QT Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biosig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate QTI or CVRX?

CVRx has a consensus price target of $11.50, suggesting a potential upside of 105.36%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00

Which has higher earnings & valuation, QTI or CVRX?

QT Imaging has higher earnings, but lower revenue than CVRx. QT Imaging is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QT Imaging $22.66M 2.15 -$21.08M -$1.24 N/A CVRx $56.65M 2.62 -$53.31M -$2.02 N/A

Is QTI or CVRX more profitable?

QT Imaging has a net margin of -58.93% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -58.93% -4,220.38% -51.77% CVRx -89.14% -120.76% -48.38%

Do analysts recommend QTI or GUTS?

Fractyl Health has a consensus price target of $5.12, indicating a potential upside of 571.92%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts plainly believe Fractyl Health is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Fractyl Health 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Is QTI or GUTS more profitable?

Fractyl Health has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Fractyl Health's return on equity of -4,053.15% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -58.93% -4,220.38% -51.77% Fractyl Health N/A -4,053.15% -96.41%

QT Imaging (QTI) Competitors

$4.05 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$3.90 -0.15 (-3.80%)

As of 07/2/2026 07:47 PM Eastern

Compare

QTI vs. APYX, HYPR, STEX, CVRX, and GUTS

Should you buy QT Imaging stock or one of its competitors? MarketBeat compares QT Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QT Imaging include Apyx Medical (APYX), Hyperfine (HYPR), Biosig Technologies (STEX), CVRx (CVRX), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry.

How does QT Imaging compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Apyx Medical has a net margin of -16.40% compared to QT Imaging's net margin of -58.93%. Apyx Medical's return on equity of -88.47% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 51.16%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Apyx Medical is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 28.8% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. QT Imaging's average media sentiment score of 1.34 beat Apyx Medical's score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Apyx Medical has higher revenue and earnings than QT Imaging. Apyx Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	3.41	-$11.21M	-$0.22	N/A
QT Imaging	$22.66M	2.15	-$21.08M	-$1.24	N/A

Apyx Medical has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, meaning that its stock price is 104% less volatile than the broader market.

Summary

Apyx Medical beats QT Imaging on 13 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Hyperfine?

QT Imaging (NASDAQ:QTI) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, Hyperfine had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Hyperfine and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.34 beat Hyperfine's score of 0.00 indicating that QT Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hyperfine	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hyperfine has a consensus price target of $1.78, suggesting a potential upside of 37.18%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts plainly believe Hyperfine is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 28.8% of QT Imaging shares are held by insiders. Comparatively, 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

QT Imaging has a beta of -0.04, meaning that its stock price is 104% less volatile than the broader market. Comparatively, Hyperfine has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

QT Imaging has a net margin of -58.93% compared to Hyperfine's net margin of -226.88%. Hyperfine's return on equity of -98.83% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
Hyperfine	-226.88%	-98.83%	-67.09%

QT Imaging has higher revenue and earnings than Hyperfine. QT Imaging is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$22.66M	2.15	-$21.08M	-$1.24	N/A
Hyperfine	$11.40M	11.32	-$35.57M	-$0.41	N/A

Summary

Hyperfine beats QT Imaging on 9 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Biosig Technologies?

QT Imaging (NASDAQ:QTI) and Biosig Technologies (NASDAQ:STEX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Biosig Technologies has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Biosig Technologies' return on equity of -717.92% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
Biosig Technologies	N/A	-717.92%	-336.75%

QT Imaging has a beta of -0.04, meaning that its stock price is 104% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market.

In the previous week, Biosig Technologies had 1 more articles in the media than QT Imaging. MarketBeat recorded 2 mentions for Biosig Technologies and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.34 beat Biosig Technologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QT Imaging	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biosig Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 52.7% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

QT Imaging has higher revenue and earnings than Biosig Technologies. QT Imaging is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$22.66M	2.15	-$21.08M	-$1.24	N/A
Biosig Technologies	$40K	4,411.83	-$462.77M	-$9.71	N/A

Biosig Technologies has a consensus price target of $8.00, suggesting a potential upside of 724.15%. Given Biosig Technologies' higher possible upside, analysts clearly believe Biosig Technologies is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Biosig Technologies beats QT Imaging on 8 of the 14 factors compared between the two stocks.

How does QT Imaging compare to CVRx?

QT Imaging (NASDAQ:QTI) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

In the previous week, QT Imaging had 1 more articles in the media than CVRx. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for CVRx. QT Imaging's average media sentiment score of 1.34 beat CVRx's score of 1.00 indicating that QT Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
QT Imaging	Positive
CVRx	Positive

QT Imaging has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

CVRx has a consensus price target of $11.50, suggesting a potential upside of 105.36%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

QT Imaging has higher earnings, but lower revenue than CVRx. QT Imaging is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$22.66M	2.15	-$21.08M	-$1.24	N/A
CVRx	$56.65M	2.62	-$53.31M	-$2.02	N/A

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 28.8% of QT Imaging shares are owned by insiders. Comparatively, 13.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

QT Imaging has a net margin of -58.93% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
CVRx	-89.14%	-120.76%	-48.38%

Summary

CVRx beats QT Imaging on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Fractyl Health?

QT Imaging (NASDAQ:QTI) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

Fractyl Health has a consensus price target of $5.12, indicating a potential upside of 571.92%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts plainly believe Fractyl Health is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

24.2% of QT Imaging shares are owned by institutional investors. 28.8% of QT Imaging shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

QT Imaging has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, meaning that its share price is 129% more volatile than the broader market.

In the previous week, QT Imaging and QT Imaging both had 1 articles in the media. QT Imaging's average media sentiment score of 1.34 beat Fractyl Health's score of 1.00 indicating that QT Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
QT Imaging	Positive
Fractyl Health	Positive

Fractyl Health has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Fractyl Health's return on equity of -4,053.15% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
Fractyl Health	N/A	-4,053.15%	-96.41%

QT Imaging has higher revenue and earnings than Fractyl Health. QT Imaging is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$22.66M	2.15	-$21.08M	-$1.24	N/A
Fractyl Health	N/A	N/A	-$140.95M	-$1.29	N/A

Summary

QT Imaging and Fractyl Health tied by winning 7 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTI vs. The Competition

Export

Metric	QT Imaging	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$48.77M	$80.63M	$7.16B	$12.48B
Dividend Yield	N/A	N/A	2.66%	6.52%
P/E Ratio	-3.27	10.10	28.02	24.70
Price / Sales	2.15	192.41	540.37	99.49
Price / Cash	N/A	41.36	49.26	57.09
Price / Book	7.50	5.57	10.96	6.46
Net Income	-$21.08M	-$5.50M	$3.57B	$337.01M
7 Day Performance	-0.49%	4.59%	2.12%	1.69%
1 Month Performance	5.47%	6.31%	5.25%	3.81%
1 Year Performance	185.61%	116.90%	33.29%	23.90%

QT Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTI QT Imaging	1.548 of 5 stars	$4.05 flat	N/A	+185.6%	$48.77M	$22.66M	N/A	N/A	Positive News
APYX Apyx Medical	2.4237 of 5 stars	$4.17 +1.2%	$6.50 +55.9%	+87.4%	$172.52M	$52.84M	N/A	270
HYPR Hyperfine	2.5505 of 5 stars	$1.69 +15.8%	$1.78 +5.5%	+64.8%	$144.93M	$11.40M	N/A	190	High Trading Volume
STEX Biosig Technologies	1.6376 of 5 stars	$0.74 -5.4%	$8.00 +980.9%	N/A	$142.28M	$40K	N/A	50	News Coverage Gap Up
CVRX CVRx	3.3482 of 5 stars	$5.25 +1.7%	$11.50 +119.0%	-14.9%	$136.79M	$56.65M	N/A	160

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTI) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Competitors

QTI vs. APYX, HYPR, STEX, CVRX, and GUTS

How does QT Imaging compare to Apyx Medical?

Summary

How does QT Imaging compare to Hyperfine?

Summary

How does QT Imaging compare to Biosig Technologies?

Summary

How does QT Imaging compare to CVRx?

Summary

How does QT Imaging compare to Fractyl Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Competitors

QTI vs. APYX, HYPR, STEX, CVRX, and GUTS

How does QT Imaging compare to Apyx Medical?

Is APYX or QTI more profitable?

Do analysts rate APYX or QTI?

Do institutionals and insiders have more ownership in APYX or QTI?

Does the media refer more to APYX or QTI?

Which has better valuation & earnings, APYX or QTI?

Which has more risk & volatility, APYX or QTI?

Summary

How does QT Imaging compare to Hyperfine?

Does the media prefer QTI or HYPR?

Do analysts rate QTI or HYPR?

Do institutionals & insiders believe in QTI or HYPR?

Which has more volatility & risk, QTI or HYPR?

Is QTI or HYPR more profitable?

Which has stronger valuation and earnings, QTI or HYPR?

Summary

How does QT Imaging compare to Biosig Technologies?

Is QTI or STEX more profitable?

Which has more risk and volatility, QTI or STEX?

Does the media prefer QTI or STEX?

Do insiders & institutionals believe in QTI or STEX?

Which has higher earnings & valuation, QTI or STEX?

Do analysts recommend QTI or STEX?

Summary

How does QT Imaging compare to CVRx?

Does the media refer more to QTI or CVRX?

Which has more volatility & risk, QTI or CVRX?

Do analysts rate QTI or CVRX?

Which has higher earnings & valuation, QTI or CVRX?

Do insiders and institutionals hold more shares of QTI or CVRX?

Is QTI or CVRX more profitable?

Summary

How does QT Imaging compare to Fractyl Health?

Do analysts recommend QTI or GUTS?

Do institutionals & insiders believe in QTI or GUTS?

Which has more volatility & risk, QTI or GUTS?

Does the media refer more to QTI or GUTS?

Is QTI or GUTS more profitable?

Which has higher valuation and earnings, QTI or GUTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools